Evidence map›Paper›PMID 19029332›Full record

ArticleAntimicrobial agents and chemotherapy2009

Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition.

Triinu Siibak, Lauri Peil, Liqun Xiong, Alexander Mankin, Jaanus Remme, Tanel Tenson

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 86 citations in OpenAlex.

  1. Sublethal Concentration of Chloramphenicol Threatens the Health ofInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Antibiotics targeting bacterial ribosomal subunit biogenesis.The Journal of antimicrobial chemotherapy · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. The macrolide antibiotic renaissance.British journal of pharmacology · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. An evolutionarily conserved element in initiator tRNAs prompts ultimate steps in ribosome maturation.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Triinu SiibakInstitute of Molecular and Cell Biology, University of Tartu, Estonia.
Lauri Peil
Liqun Xiong
Alexander Mankin
Jaanus Remme
Tanel Tenson
University of Tartu · EEAshland (United States) · US

Funding

New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureusR01AI072445 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MANKIN, ALEXANDER S · 2007 to 2010
$1.6M
NIAID NIH HHS AI072445NIAID NIH HHS R01 AI072445Wellcome Trust
6 · The paper itself

Abstract

Several protein synthesis inhibitors are known to inhibit ribosome assembly. This may be a consequence of direct binding of the antibiotic to ribosome precursor particles, or it could result indirectly from loss of coordination in the production of ribosomal components due to the inhibition of protein synthesis. Here we demonstrate that erythromycin and chloramphenicol, inhibitors of the large ribosomal subunit, affect the assembly of both the large and small subunits. Expression of a small erythromycin resistance peptide acting in cis on mature ribosomes relieves the erythromycin-mediated assembly defect for both subunits. Erythromycin treatment of bacteria expressing a mixture of erythromycin-sensitive and -resistant ribosomes produced comparable effects on subunit assembly. These results argue in favor of the view that erythromycin and chloramphenicol affect the assembly of the large ribosomal subunit indirectly.

Indexed as

Anti-Bacterial AgentsChloramphenicolDrug Resistance, BacterialElectrophoresis, Gel, Pulsed-FieldErythromycinEscherichia coliProtein Synthesis InhibitorsRibosomesRNA, BacterialRNA, RibosomalStaphylococcus aureusAnti-Bacterial AgentsChloramphenicolErythromycinProtein Synthesis InhibitorsRNA, BacterialRNA, Ribosomal

Identifiers

PMID19029332
PMCPMC2630658
OpenAlexW2084456919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.